Lilly Oncology, a global leader in thoracic cancer treatment, will be presenting important data on its emerging research in breast cancer therapy at the 42nd annual American Society for Clinical Oncology (ASCO) meeting in Atlanta, Ga., June 2-6, 2006. Among the 79 studies being presented by Lilly Oncology, data from 11 clinical studies focus on
Archive for the 'Gemcitabine' Category
GemzarÂ® (gemcitabine HCl) is an anticancer drug that interferes with the processes of DNA production; by doing so, Gemzar prevents cancer cells from replicating and thus slows or stops tumor growth.
Last update: March 06, 2014. 08:41:31 pm.